| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 90 | 2025 | 1081 | 17.710 |
Why?
|
| Heart Failure | 58 | 2025 | 2401 | 7.960 |
Why?
|
| Heart Transplantation | 39 | 2025 | 883 | 6.690 |
Why?
|
| Heart Defects, Congenital | 44 | 2025 | 1859 | 5.610 |
Why?
|
| Fontan Procedure | 19 | 2021 | 186 | 4.790 |
Why?
|
| Prosthesis Implantation | 9 | 2019 | 153 | 3.410 |
Why?
|
| Pulmonary Artery | 18 | 2024 | 459 | 3.090 |
Why?
|
| Heart Ventricles | 23 | 2024 | 783 | 2.720 |
Why?
|
| Cardiomyopathy, Dilated | 7 | 2022 | 215 | 2.530 |
Why?
|
| Child | 111 | 2025 | 25763 | 1.940 |
Why?
|
| Treatment Outcome | 82 | 2025 | 13000 | 1.890 |
Why?
|
| Heart Septal Defects, Ventricular | 10 | 2018 | 133 | 1.790 |
Why?
|
| Cardiac Surgical Procedures | 21 | 2025 | 1173 | 1.750 |
Why?
|
| Extracorporeal Membrane Oxygenation | 11 | 2025 | 661 | 1.640 |
Why?
|
| Transposition of Great Vessels | 6 | 2020 | 133 | 1.610 |
Why?
|
| Pulmonary Atresia | 4 | 2025 | 49 | 1.570 |
Why?
|
| Humans | 202 | 2025 | 132064 | 1.530 |
Why?
|
| Registries | 15 | 2025 | 1596 | 1.510 |
Why?
|
| Child, Preschool | 73 | 2025 | 14734 | 1.490 |
Why?
|
| Infant | 75 | 2025 | 13048 | 1.450 |
Why?
|
| Prosthesis Design | 22 | 2024 | 666 | 1.400 |
Why?
|
| Heart | 7 | 2023 | 689 | 1.390 |
Why?
|
| Heart, Artificial | 3 | 2019 | 69 | 1.370 |
Why?
|
| Ventricular Function, Left | 9 | 2022 | 546 | 1.360 |
Why?
|
| Ventricular Dysfunction, Right | 4 | 2020 | 79 | 1.360 |
Why?
|
| Retrospective Studies | 80 | 2025 | 17389 | 1.330 |
Why?
|
| Vascular Diseases | 3 | 2022 | 150 | 1.310 |
Why?
|
| Device Removal | 6 | 2019 | 225 | 1.260 |
Why?
|
| Cardiomyopathies | 5 | 2022 | 508 | 1.170 |
Why?
|
| Heart Atria | 6 | 2020 | 336 | 1.160 |
Why?
|
| Adolescent | 63 | 2025 | 20542 | 1.120 |
Why?
|
| Coronary Circulation | 5 | 2022 | 206 | 1.110 |
Why?
|
| Time Factors | 35 | 2025 | 6444 | 1.070 |
Why?
|
| Reoperation | 18 | 2021 | 852 | 1.050 |
Why?
|
| Heart Septal Defects, Atrial | 5 | 2020 | 123 | 1.020 |
Why?
|
| Heart Valve Diseases | 4 | 2021 | 178 | 0.990 |
Why?
|
| Graft Rejection | 5 | 2024 | 559 | 0.930 |
Why?
|
| Coronary Vessels | 5 | 2024 | 548 | 0.930 |
Why?
|
| Tricuspid Atresia | 2 | 2018 | 14 | 0.920 |
Why?
|
| Ebstein Anomaly | 4 | 2013 | 29 | 0.910 |
Why?
|
| Surgeons | 3 | 2023 | 286 | 0.880 |
Why?
|
| Arterial Switch Operation | 3 | 2020 | 24 | 0.870 |
Why?
|
| Prosthesis-Related Infections | 3 | 2018 | 187 | 0.850 |
Why?
|
| Allografts | 3 | 2024 | 196 | 0.850 |
Why?
|
| Palliative Care | 4 | 2021 | 456 | 0.840 |
Why?
|
| Female | 94 | 2025 | 70664 | 0.830 |
Why?
|
| Thrombosis | 3 | 2022 | 524 | 0.810 |
Why?
|
| Tricuspid Valve | 4 | 2016 | 61 | 0.810 |
Why?
|
| Heart Valve Prosthesis Implantation | 5 | 2020 | 458 | 0.810 |
Why?
|
| Vascular Surgical Procedures | 10 | 2021 | 552 | 0.810 |
Why?
|
| Coronary Vessel Anomalies | 5 | 2024 | 289 | 0.800 |
Why?
|
| Cannula | 2 | 2020 | 31 | 0.780 |
Why?
|
| Hospitals, Pediatric | 5 | 2019 | 777 | 0.770 |
Why?
|
| Male | 88 | 2025 | 64938 | 0.770 |
Why?
|
| Waiting Lists | 5 | 2020 | 237 | 0.770 |
Why?
|
| Elementary Particles | 5 | 2014 | 14 | 0.770 |
Why?
|
| Mitral Valve | 5 | 2021 | 268 | 0.770 |
Why?
|
| Lung Transplantation | 6 | 2022 | 336 | 0.740 |
Why?
|
| Ventricular Septum | 1 | 2022 | 16 | 0.740 |
Why?
|
| Follow-Up Studies | 25 | 2025 | 5412 | 0.730 |
Why?
|
| Infant, Newborn | 37 | 2025 | 8542 | 0.720 |
Why?
|
| Pericardium | 3 | 2007 | 91 | 0.710 |
Why?
|
| Postoperative Complications | 13 | 2024 | 3137 | 0.690 |
Why?
|
| Tissue and Organ Procurement | 5 | 2020 | 246 | 0.690 |
Why?
|
| Cardiac Catheterization | 7 | 2022 | 663 | 0.680 |
Why?
|
| Truncus Arteriosus, Persistent | 3 | 2021 | 18 | 0.660 |
Why?
|
| Aorta, Thoracic | 9 | 2024 | 540 | 0.660 |
Why?
|
| Models, Cardiovascular | 3 | 2021 | 183 | 0.640 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2021 | 185 | 0.640 |
Why?
|
| Quantum Theory | 6 | 2014 | 22 | 0.640 |
Why?
|
| Recovery of Function | 8 | 2024 | 462 | 0.640 |
Why?
|
| Endocarditis, Bacterial | 2 | 2018 | 137 | 0.630 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2019 | 53 | 0.620 |
Why?
|
| Macrophages | 1 | 2024 | 691 | 0.620 |
Why?
|
| Graft Survival | 7 | 2024 | 473 | 0.610 |
Why?
|
| Endocardial Cushion Defects | 2 | 2009 | 7 | 0.610 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 32 | 0.610 |
Why?
|
| Abnormalities, Multiple | 8 | 2024 | 981 | 0.600 |
Why?
|
| Cardiopulmonary Bypass | 6 | 2021 | 373 | 0.600 |
Why?
|
| Hemodynamics | 8 | 2022 | 857 | 0.590 |
Why?
|
| Single Photon Emission Computed Tomography Computed Tomography | 1 | 2018 | 6 | 0.590 |
Why?
|
| Stroke | 2 | 2024 | 1081 | 0.580 |
Why?
|
| Materials Testing | 1 | 2018 | 78 | 0.570 |
Why?
|
| Hypoplastic Left Heart Syndrome | 5 | 2024 | 271 | 0.570 |
Why?
|
| Heparin | 3 | 2022 | 212 | 0.550 |
Why?
|
| Stents | 3 | 2016 | 868 | 0.550 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2018 | 134 | 0.540 |
Why?
|
| Hemostasis | 1 | 2017 | 73 | 0.540 |
Why?
|
| Age Factors | 14 | 2020 | 2911 | 0.540 |
Why?
|
| Prosthesis Failure | 4 | 2019 | 163 | 0.530 |
Why?
|
| Ventricular Function | 2 | 2017 | 91 | 0.530 |
Why?
|
| Surgical Fixation Devices | 1 | 2017 | 3 | 0.530 |
Why?
|
| Thoracic Surgery | 3 | 2025 | 166 | 0.520 |
Why?
|
| Titanium | 1 | 2017 | 26 | 0.520 |
Why?
|
| Heart Valve Prosthesis | 4 | 2020 | 328 | 0.520 |
Why?
|
| Anthracyclines | 1 | 2017 | 44 | 0.520 |
Why?
|
| Anticoagulants | 4 | 2022 | 607 | 0.510 |
Why?
|
| Wound Closure Techniques | 1 | 2017 | 27 | 0.510 |
Why?
|
| Abscess | 2 | 2009 | 140 | 0.510 |
Why?
|
| Young Adult | 22 | 2024 | 9952 | 0.500 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 2016 | 14 | 0.490 |
Why?
|
| Heart Diseases | 2 | 2020 | 511 | 0.490 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2017 | 128 | 0.490 |
Why?
|
| Rectus Abdominis | 1 | 2015 | 9 | 0.480 |
Why?
|
| Survival Rate | 14 | 2024 | 2193 | 0.480 |
Why?
|
| Miniaturization | 4 | 2024 | 26 | 0.480 |
Why?
|
| Atrial Pressure | 1 | 2015 | 6 | 0.470 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2015 | 22 | 0.470 |
Why?
|
| Equipment Design | 6 | 2020 | 600 | 0.470 |
Why?
|
| Hospitals, Low-Volume | 1 | 2015 | 32 | 0.450 |
Why?
|
| Hospitals, High-Volume | 1 | 2015 | 41 | 0.450 |
Why?
|
| Adult | 36 | 2024 | 31571 | 0.430 |
Why?
|
| Double Outlet Right Ventricle | 3 | 2010 | 21 | 0.420 |
Why?
|
| Aortic Valve Insufficiency | 5 | 2019 | 157 | 0.420 |
Why?
|
| Nuclear Physics | 4 | 2014 | 17 | 0.410 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2013 | 48 | 0.410 |
Why?
|
| Risk Factors | 24 | 2024 | 10938 | 0.410 |
Why?
|
| Compassionate Use Trials | 1 | 2013 | 16 | 0.400 |
Why?
|
| Shock, Cardiogenic | 3 | 2024 | 212 | 0.390 |
Why?
|
| Risk Assessment | 12 | 2024 | 3731 | 0.380 |
Why?
|
| Allied Health Personnel | 1 | 2013 | 73 | 0.370 |
Why?
|
| Dextrocardia | 1 | 2012 | 9 | 0.370 |
Why?
|
| Drug Monitoring | 1 | 2013 | 175 | 0.370 |
Why?
|
| Pediatrics | 3 | 2020 | 1211 | 0.360 |
Why?
|
| Aortic Valve | 4 | 2019 | 482 | 0.360 |
Why?
|
| Hemolysis | 3 | 2021 | 107 | 0.350 |
Why?
|
| Subclavian Artery | 1 | 2011 | 70 | 0.340 |
Why?
|
| Lung Diseases | 1 | 2015 | 408 | 0.340 |
Why?
|
| Tissue Donors | 4 | 2024 | 503 | 0.340 |
Why?
|
| Tunica Media | 1 | 2010 | 15 | 0.340 |
Why?
|
| Texas | 9 | 2020 | 3627 | 0.330 |
Why?
|
| Scoliosis | 2 | 2018 | 143 | 0.330 |
Why?
|
| Klebsiella oxytoca | 1 | 2009 | 1 | 0.320 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 2010 | 41 | 0.320 |
Why?
|
| Scimitar Syndrome | 2 | 2021 | 52 | 0.320 |
Why?
|
| Vascular Malformations | 1 | 2011 | 112 | 0.320 |
Why?
|
| Klebsiella Infections | 1 | 2009 | 60 | 0.310 |
Why?
|
| Antithrombins | 3 | 2022 | 51 | 0.300 |
Why?
|
| Norwood Procedures | 2 | 2020 | 104 | 0.300 |
Why?
|
| Ventricular Outflow Obstruction | 2 | 2009 | 88 | 0.300 |
Why?
|
| United States | 16 | 2024 | 11660 | 0.300 |
Why?
|
| Preoperative Care | 3 | 2025 | 367 | 0.290 |
Why?
|
| Catheterization | 1 | 2010 | 241 | 0.290 |
Why?
|
| Patient Care Team | 1 | 2013 | 572 | 0.290 |
Why?
|
| Heart Septal Defects | 2 | 2018 | 44 | 0.290 |
Why?
|
| Tachycardia | 2 | 2022 | 68 | 0.290 |
Why?
|
| Aortic Coarctation | 4 | 2015 | 105 | 0.280 |
Why?
|
| Surgical Flaps | 2 | 2009 | 189 | 0.270 |
Why?
|
| Outpatients | 2 | 2022 | 274 | 0.270 |
Why?
|
| Blalock-Taussig Procedure | 2 | 2020 | 49 | 0.260 |
Why?
|
| Myocardium | 3 | 2024 | 906 | 0.260 |
Why?
|
| Donor Selection | 2 | 2020 | 58 | 0.240 |
Why?
|
| Heart Aneurysm | 1 | 2005 | 37 | 0.240 |
Why?
|
| Pulsatile Flow | 2 | 2019 | 124 | 0.240 |
Why?
|
| Embolism | 1 | 2005 | 46 | 0.230 |
Why?
|
| Thoracotomy | 3 | 2019 | 110 | 0.230 |
Why?
|
| Methylprednisolone | 1 | 2025 | 98 | 0.220 |
Why?
|
| Body Size | 2 | 2017 | 68 | 0.220 |
Why?
|
| Truncus Arteriosus | 2 | 2021 | 13 | 0.220 |
Why?
|
| Cor Triatriatum | 1 | 2024 | 10 | 0.220 |
Why?
|
| Aorta | 2 | 2018 | 550 | 0.210 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2021 | 56 | 0.210 |
Why?
|
| Patient Selection | 2 | 2021 | 732 | 0.210 |
Why?
|
| Hirudins | 2 | 2022 | 36 | 0.210 |
Why?
|
| Cattle | 4 | 2021 | 569 | 0.200 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2021 | 257 | 0.200 |
Why?
|
| Consensus | 3 | 2025 | 649 | 0.200 |
Why?
|
| Respiratory Insufficiency | 2 | 2005 | 247 | 0.200 |
Why?
|
| Ventricular Remodeling | 3 | 2024 | 167 | 0.200 |
Why?
|
| Marfan Syndrome | 1 | 2005 | 148 | 0.200 |
Why?
|
| Incidental Findings | 1 | 2024 | 130 | 0.200 |
Why?
|
| Feasibility Studies | 2 | 2024 | 820 | 0.200 |
Why?
|
| Echocardiography | 6 | 2021 | 1125 | 0.200 |
Why?
|
| Atrial Flutter | 1 | 2022 | 35 | 0.190 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 305 | 0.190 |
Why?
|
| Catheters | 1 | 2022 | 89 | 0.190 |
Why?
|
| Coronary Angiography | 2 | 2019 | 487 | 0.190 |
Why?
|
| Airway Obstruction | 2 | 2016 | 167 | 0.190 |
Why?
|
| Heart Bypass, Right | 2 | 2013 | 19 | 0.180 |
Why?
|
| Coronary Disease | 1 | 2005 | 685 | 0.180 |
Why?
|
| Ventricular Function, Right | 2 | 2019 | 119 | 0.180 |
Why?
|
| Hospital Mortality | 6 | 2025 | 1075 | 0.180 |
Why?
|
| Genetic Engineering | 1 | 2022 | 164 | 0.180 |
Why?
|
| Tracheal Stenosis | 2 | 2020 | 31 | 0.180 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2022 | 106 | 0.180 |
Why?
|
| Intraoperative Complications | 2 | 2015 | 160 | 0.180 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 351 | 0.180 |
Why?
|
| Models, Theoretical | 2 | 2014 | 391 | 0.180 |
Why?
|
| Decompression, Surgical | 1 | 2021 | 91 | 0.180 |
Why?
|
| Radiopharmaceuticals | 2 | 2018 | 170 | 0.170 |
Why?
|
| Factor VIIa | 1 | 2020 | 24 | 0.170 |
Why?
|
| Atrial Fibrillation | 2 | 2022 | 737 | 0.170 |
Why?
|
| Prospective Studies | 7 | 2024 | 6570 | 0.170 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2020 | 20 | 0.170 |
Why?
|
| Aortic Valve Stenosis | 2 | 2019 | 377 | 0.160 |
Why?
|
| Kidney Diseases | 2 | 2022 | 489 | 0.160 |
Why?
|
| Developmental Disabilities | 1 | 2025 | 755 | 0.160 |
Why?
|
| Computer Simulation | 2 | 2020 | 697 | 0.160 |
Why?
|
| Shock | 1 | 2021 | 99 | 0.160 |
Why?
|
| Discrete Subaortic Stenosis | 1 | 2019 | 7 | 0.160 |
Why?
|
| Databases, Factual | 4 | 2025 | 1230 | 0.160 |
Why?
|
| Vascular Ring | 1 | 2019 | 6 | 0.160 |
Why?
|
| Berlin | 1 | 2019 | 3 | 0.160 |
Why?
|
| Biological Products | 1 | 2021 | 137 | 0.160 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2025 | 560 | 0.160 |
Why?
|
| Shock, Septic | 1 | 2021 | 155 | 0.150 |
Why?
|
| Hydrodynamics | 1 | 2019 | 28 | 0.150 |
Why?
|
| Atrioventricular Node | 2 | 2009 | 15 | 0.150 |
Why?
|
| Thrombelastography | 1 | 2019 | 63 | 0.150 |
Why?
|
| American Heart Association | 1 | 2021 | 309 | 0.150 |
Why?
|
| Heart Valves | 2 | 2009 | 52 | 0.150 |
Why?
|
| Pulmonary Veins | 1 | 2021 | 171 | 0.150 |
Why?
|
| Overweight | 1 | 2021 | 383 | 0.150 |
Why?
|
| Cardiotonic Agents | 1 | 2019 | 136 | 0.140 |
Why?
|
| Vasodilator Agents | 1 | 2019 | 208 | 0.140 |
Why?
|
| Platelet Activation | 1 | 2018 | 69 | 0.140 |
Why?
|
| Acute Kidney Injury | 2 | 2023 | 670 | 0.140 |
Why?
|
| Tracheostomy | 1 | 2020 | 204 | 0.140 |
Why?
|
| Blood Coagulation Tests | 2 | 2019 | 61 | 0.140 |
Why?
|
| Animals | 10 | 2023 | 34804 | 0.140 |
Why?
|
| Tetralogy of Fallot | 2 | 2022 | 176 | 0.140 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1998 | 105 | 0.140 |
Why?
|
| Angiography | 2 | 2010 | 208 | 0.140 |
Why?
|
| Benchmarking | 1 | 2018 | 138 | 0.140 |
Why?
|
| Walking | 1 | 2019 | 234 | 0.130 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 1822 | 0.130 |
Why?
|
| Inflammation | 1 | 2025 | 1519 | 0.130 |
Why?
|
| Cohort Studies | 7 | 2024 | 5168 | 0.130 |
Why?
|
| Pectus Carinatum | 1 | 2017 | 5 | 0.130 |
Why?
|
| Digestive System Abnormalities | 1 | 2017 | 40 | 0.130 |
Why?
|
| Cardiotoxicity | 1 | 2017 | 40 | 0.130 |
Why?
|
| von Willebrand Factor | 1 | 2018 | 192 | 0.130 |
Why?
|
| Recurrence | 2 | 2018 | 1454 | 0.130 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2019 | 342 | 0.130 |
Why?
|
| Advanced Cardiac Life Support | 2 | 2013 | 17 | 0.130 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1160 | 0.130 |
Why?
|
| Aortic Arch Syndromes | 2 | 2014 | 11 | 0.130 |
Why?
|
| Sheep | 1 | 2017 | 229 | 0.130 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2017 | 51 | 0.130 |
Why?
|
| Anemia, Sickle Cell | 1 | 2020 | 330 | 0.130 |
Why?
|
| Survival Analysis | 3 | 2017 | 1572 | 0.130 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2017 | 42 | 0.120 |
Why?
|
| Middle Aged | 14 | 2024 | 28993 | 0.120 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2018 | 141 | 0.120 |
Why?
|
| Pulmonary Circulation | 2 | 2022 | 116 | 0.120 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2018 | 107 | 0.120 |
Why?
|
| Blood Circulation | 1 | 2016 | 17 | 0.120 |
Why?
|
| Milrinone | 1 | 2016 | 30 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2023 | 1061 | 0.120 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2019 | 244 | 0.120 |
Why?
|
| Bronchial Arteries | 1 | 2015 | 4 | 0.120 |
Why?
|
| Abdominal Muscles | 1 | 2015 | 28 | 0.120 |
Why?
|
| Energy Intake | 1 | 2018 | 493 | 0.120 |
Why?
|
| Thoracic Wall | 1 | 2016 | 40 | 0.120 |
Why?
|
| Primary Graft Dysfunction | 1 | 2015 | 26 | 0.120 |
Why?
|
| Thoracic Injuries | 1 | 2016 | 90 | 0.120 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2016 | 64 | 0.120 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2015 | 114 | 0.110 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 1710 | 0.110 |
Why?
|
| Autopsy | 3 | 2009 | 117 | 0.110 |
Why?
|
| Cause of Death | 1 | 2017 | 510 | 0.110 |
Why?
|
| Hemorrhage | 2 | 2022 | 519 | 0.110 |
Why?
|
| Chronic Disease | 2 | 2017 | 1234 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 846 | 0.110 |
Why?
|
| Anemia | 1 | 2018 | 350 | 0.110 |
Why?
|
| Infusions, Intravenous | 1 | 2016 | 547 | 0.110 |
Why?
|
| Bronchoscopy | 2 | 2015 | 174 | 0.110 |
Why?
|
| Cyanosis | 1 | 2014 | 43 | 0.110 |
Why?
|
| Perioperative Period | 1 | 2014 | 52 | 0.110 |
Why?
|
| Predictive Value of Tests | 4 | 2019 | 2311 | 0.110 |
Why?
|
| Stroke Volume | 1 | 2017 | 536 | 0.110 |
Why?
|
| Trisomy | 1 | 2014 | 112 | 0.110 |
Why?
|
| Anastomosis, Surgical | 3 | 2014 | 167 | 0.110 |
Why?
|
| Elementary Particle Interactions | 1 | 2013 | 5 | 0.100 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2016 | 221 | 0.100 |
Why?
|
| Prosthesis Fitting | 1 | 2013 | 11 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2018 | 785 | 0.100 |
Why?
|
| Recombinant Proteins | 3 | 2022 | 1350 | 0.100 |
Why?
|
| Blood Pressure | 2 | 2010 | 1400 | 0.100 |
Why?
|
| Body Weight | 1 | 2017 | 994 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 1957 | 0.100 |
Why?
|
| Incidence | 4 | 2024 | 3375 | 0.090 |
Why?
|
| Phenotype | 1 | 2022 | 4527 | 0.090 |
Why?
|
| Blood Vessel Prosthesis | 3 | 2015 | 515 | 0.090 |
Why?
|
| Dissection | 2 | 2009 | 59 | 0.090 |
Why?
|
| Spectrum Analysis | 1 | 2012 | 66 | 0.090 |
Why?
|
| Sternotomy | 1 | 2012 | 43 | 0.090 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2012 | 86 | 0.090 |
Why?
|
| Tomography, Spiral Computed | 1 | 2011 | 15 | 0.090 |
Why?
|
| Thermodynamics | 1 | 2012 | 145 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2017 | 1127 | 0.090 |
Why?
|
| Ambulatory Care | 1 | 2015 | 410 | 0.090 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2011 | 19 | 0.090 |
Why?
|
| Societies, Medical | 3 | 2025 | 779 | 0.090 |
Why?
|
| Equipment Safety | 1 | 2011 | 37 | 0.090 |
Why?
|
| Assisted Circulation | 1 | 2011 | 37 | 0.090 |
Why?
|
| Disease Management | 1 | 2015 | 563 | 0.090 |
Why?
|
| Aortography | 1 | 2011 | 183 | 0.080 |
Why?
|
| Elastic Tissue | 1 | 2010 | 19 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2013 | 313 | 0.080 |
Why?
|
| Diastole | 1 | 2011 | 181 | 0.080 |
Why?
|
| Sensitivity and Specificity | 4 | 2009 | 2139 | 0.080 |
Why?
|
| Obesity | 2 | 2021 | 2398 | 0.080 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2014 | 333 | 0.080 |
Why?
|
| Oxygen Consumption | 1 | 2011 | 305 | 0.080 |
Why?
|
| Organ Size | 1 | 2011 | 446 | 0.080 |
Why?
|
| Heart Septum | 1 | 2009 | 55 | 0.080 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 254 | 0.080 |
Why?
|
| Vascular Resistance | 1 | 2010 | 195 | 0.080 |
Why?
|
| Heart Arrest | 1 | 2014 | 374 | 0.080 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2015 | 787 | 0.080 |
Why?
|
| Prognosis | 3 | 2023 | 5010 | 0.080 |
Why?
|
| Endothelial Cells | 2 | 2023 | 526 | 0.080 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 477 | 0.080 |
Why?
|
| Sampling Studies | 1 | 2009 | 77 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 662 | 0.070 |
Why?
|
| Cadaver | 1 | 2009 | 119 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2012 | 374 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 893 | 0.070 |
Why?
|
| Proportional Hazards Models | 3 | 2018 | 1457 | 0.070 |
Why?
|
| Oxygen | 1 | 2012 | 569 | 0.070 |
Why?
|
| Brain | 2 | 1998 | 3181 | 0.070 |
Why?
|
| Pneumonectomy | 1 | 2009 | 148 | 0.070 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2024 | 1009 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2016 | 2164 | 0.070 |
Why?
|
| Multicenter Studies as Topic | 2 | 2022 | 309 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2015 | 1074 | 0.070 |
Why?
|
| Fetal Heart | 1 | 2009 | 135 | 0.070 |
Why?
|
| Venae Cavae | 1 | 2007 | 11 | 0.070 |
Why?
|
| Heart Conduction System | 1 | 2008 | 156 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2009 | 312 | 0.070 |
Why?
|
| Aortic Stenosis, Subvalvular | 1 | 2007 | 6 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2013 | 995 | 0.070 |
Why?
|
| Diagnostic Errors | 1 | 2011 | 347 | 0.070 |
Why?
|
| Epidemiologic Methods | 1 | 2007 | 99 | 0.070 |
Why?
|
| Quality of Life | 2 | 2015 | 2158 | 0.070 |
Why?
|
| Terminology as Topic | 1 | 2008 | 232 | 0.070 |
Why?
|
| Peptide Fragments | 2 | 2022 | 800 | 0.070 |
Why?
|
| Trachea | 2 | 2020 | 210 | 0.060 |
Why?
|
| Polyglycolic Acid | 2 | 1996 | 23 | 0.060 |
Why?
|
| Body Composition | 2 | 2019 | 550 | 0.060 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 1996 | 104 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 4684 | 0.060 |
Why?
|
| Lactic Acid | 2 | 1996 | 153 | 0.060 |
Why?
|
| Paclitaxel | 2 | 1996 | 140 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 333 | 0.060 |
Why?
|
| Swine | 2 | 2021 | 1178 | 0.060 |
Why?
|
| Microcirculation | 1 | 2006 | 117 | 0.060 |
Why?
|
| Spirometry | 1 | 2005 | 75 | 0.060 |
Why?
|
| Treatment Failure | 2 | 2019 | 364 | 0.060 |
Why?
|
| Tegafur | 2 | 2003 | 2 | 0.060 |
Why?
|
| Exercise | 1 | 2011 | 858 | 0.060 |
Why?
|
| Cardiomegaly | 1 | 2005 | 124 | 0.060 |
Why?
|
| Signal Transduction | 3 | 2023 | 4710 | 0.050 |
Why?
|
| Withholding Treatment | 1 | 2024 | 71 | 0.050 |
Why?
|
| Aged | 11 | 2021 | 21426 | 0.050 |
Why?
|
| Oxonic Acid | 1 | 2003 | 2 | 0.050 |
Why?
|
| Ductus Arteriosus | 1 | 2024 | 61 | 0.050 |
Why?
|
| Disease-Free Survival | 3 | 2015 | 956 | 0.050 |
Why?
|
| Image Cytometry | 1 | 2022 | 11 | 0.050 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2022 | 11 | 0.050 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2022 | 56 | 0.050 |
Why?
|
| Peritoneal Neoplasms | 1 | 2003 | 57 | 0.050 |
Why?
|
| Biology | 1 | 2022 | 26 | 0.050 |
Why?
|
| Thorax | 1 | 2022 | 73 | 0.050 |
Why?
|
| Reference Values | 2 | 2017 | 703 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2025 | 464 | 0.050 |
Why?
|
| Respiration, Artificial | 1 | 2005 | 504 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 1439 | 0.050 |
Why?
|
| Transplantation, Heterologous | 1 | 2022 | 271 | 0.050 |
Why?
|
| Pyridines | 1 | 2003 | 249 | 0.050 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2003 | 193 | 0.040 |
Why?
|
| Cardiac Output | 1 | 2022 | 166 | 0.040 |
Why?
|
| Thinness | 1 | 2021 | 73 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2022 | 338 | 0.040 |
Why?
|
| ROC Curve | 1 | 2023 | 600 | 0.040 |
Why?
|
| Lung | 2 | 2021 | 1556 | 0.040 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2022 | 157 | 0.040 |
Why?
|
| Comorbidity | 2 | 2017 | 1606 | 0.040 |
Why?
|
| Adjustment Disorders | 1 | 2000 | 4 | 0.040 |
Why?
|
| Replantation | 1 | 2020 | 56 | 0.040 |
Why?
|
| Monocytes | 1 | 2022 | 342 | 0.040 |
Why?
|
| Body Weights and Measures | 1 | 2019 | 39 | 0.040 |
Why?
|
| Retreatment | 1 | 2020 | 93 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2022 | 386 | 0.040 |
Why?
|
| Half-Life | 1 | 2019 | 160 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 1539 | 0.040 |
Why?
|
| Technetium Tc 99m Mertiatide | 1 | 1999 | 1 | 0.040 |
Why?
|
| Radioisotope Renography | 1 | 1999 | 3 | 0.040 |
Why?
|
| Polymers | 2 | 1996 | 108 | 0.040 |
Why?
|
| Hypothermia, Induced | 1 | 2020 | 170 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 347 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 258 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 2018 | 91 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2022 | 861 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 748 | 0.040 |
Why?
|
| Scattering, Radiation | 1 | 1998 | 56 | 0.030 |
Why?
|
| Iodobenzenes | 1 | 1997 | 1 | 0.030 |
Why?
|
| Bisoprolol | 1 | 1997 | 9 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2018 | 153 | 0.030 |
Why?
|
| Stomach Neoplasms | 1 | 2003 | 565 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2022 | 652 | 0.030 |
Why?
|
| Chitin | 1 | 1996 | 5 | 0.030 |
Why?
|
| Iodine Radioisotopes | 1 | 1997 | 75 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2022 | 698 | 0.030 |
Why?
|
| Kidney | 1 | 2023 | 1329 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 436 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2017 | 3412 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1442 | 0.030 |
Why?
|
| Gestational Age | 1 | 2020 | 1226 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 1671 | 0.030 |
Why?
|
| Linear Models | 1 | 2018 | 713 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2003 | 1017 | 0.030 |
Why?
|
| Disease Progression | 1 | 2022 | 2227 | 0.030 |
Why?
|
| Bronchi | 1 | 2016 | 103 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 378 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1997 | 223 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2021 | 1698 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 215 | 0.030 |
Why?
|
| Hospitalization | 1 | 2024 | 1900 | 0.030 |
Why?
|
| Length of Stay | 1 | 2021 | 1380 | 0.030 |
Why?
|
| Cisplatin | 1 | 1996 | 280 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2000 | 575 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 197 | 0.030 |
Why?
|
| Brain Diseases | 1 | 1998 | 306 | 0.030 |
Why?
|
| Depressive Disorder, Major | 1 | 2000 | 440 | 0.030 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2014 | 16 | 0.030 |
Why?
|
| Bioprosthesis | 1 | 2015 | 118 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2014 | 61 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 1998 | 476 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1351 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2000 | 1305 | 0.030 |
Why?
|
| Fluorodeoxyuridylate | 1 | 1993 | 2 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 102 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2015 | 618 | 0.030 |
Why?
|
| Thymidylate Synthase | 1 | 1993 | 21 | 0.020 |
Why?
|
| Infant Mortality | 1 | 2014 | 179 | 0.020 |
Why?
|
| Microspheres | 3 | 1996 | 73 | 0.020 |
Why?
|
| Photons | 1 | 2012 | 53 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 212 | 0.020 |
Why?
|
| Inhalation | 1 | 2012 | 8 | 0.020 |
Why?
|
| Partial Pressure | 1 | 2012 | 28 | 0.020 |
Why?
|
| Vacuoles | 1 | 1992 | 29 | 0.020 |
Why?
|
| Particle Size | 3 | 1996 | 149 | 0.020 |
Why?
|
| Proton-Translocating ATPases | 1 | 1992 | 18 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2013 | 271 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2017 | 843 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2012 | 76 | 0.020 |
Why?
|
| Prevalence | 1 | 2018 | 2657 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2013 | 385 | 0.020 |
Why?
|
| Pregnancy | 1 | 2024 | 7554 | 0.020 |
Why?
|
| Fibrosis | 1 | 2013 | 421 | 0.020 |
Why?
|
| Folic Acid | 1 | 1993 | 288 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 588 | 0.020 |
Why?
|
| Chordae Tendineae | 1 | 2008 | 7 | 0.020 |
Why?
|
| Mice | 2 | 2023 | 18478 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 322 | 0.020 |
Why?
|
| Critical Care | 1 | 2013 | 687 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2000 | 2647 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 3842 | 0.020 |
Why?
|
| Myristates | 2 | 1996 | 3 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2007 | 235 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 1993 | 632 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2442 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 1996 | 136 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2007 | 373 | 0.020 |
Why?
|
| Angioplasty, Balloon | 1 | 2007 | 156 | 0.020 |
Why?
|
| Epilepsy | 1 | 1994 | 889 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 1300 | 0.020 |
Why?
|
| Drug Carriers | 2 | 1996 | 119 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1993 | 1340 | 0.010 |
Why?
|
| Pacemaker, Artificial | 1 | 2007 | 187 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 3760 | 0.010 |
Why?
|
| Achlorhydria | 1 | 1984 | 6 | 0.010 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1984 | 15 | 0.010 |
Why?
|
| Hypokalemia | 1 | 1984 | 42 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 2554 | 0.010 |
Why?
|
| Logistic Models | 2 | 2000 | 1839 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2003 | 280 | 0.010 |
Why?
|
| Biomarkers | 1 | 2012 | 3403 | 0.010 |
Why?
|
| Diarrhea | 1 | 1984 | 331 | 0.010 |
Why?
|
| Emergencies | 1 | 1983 | 186 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2003 | 696 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 7107 | 0.010 |
Why?
|
| Aortic Aneurysm | 1 | 1983 | 237 | 0.010 |
Why?
|
| Japan | 1 | 2000 | 156 | 0.010 |
Why?
|
| Pulmonary Atelectasis | 1 | 1979 | 14 | 0.010 |
Why?
|
| Affect | 1 | 2000 | 173 | 0.010 |
Why?
|
| Aortic Rupture | 1 | 1979 | 119 | 0.010 |
Why?
|
| Social Support | 1 | 2000 | 387 | 0.010 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 1997 | 12 | 0.010 |
Why?
|
| Pain | 1 | 2000 | 457 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1997 | 144 | 0.010 |
Why?
|
| Adsorption | 1 | 1996 | 36 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2000 | 902 | 0.010 |
Why?
|
| Chitosan | 1 | 1996 | 31 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1996 | 308 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1996 | 380 | 0.010 |
Why?
|
| Area Under Curve | 1 | 1996 | 321 | 0.010 |
Why?
|
| Uracil | 1 | 1993 | 14 | 0.010 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 1994 | 91 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1992 | 180 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1992 | 213 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1992 | 252 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 261 | 0.010 |
Why?
|
| Dogs | 1 | 1992 | 652 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1992 | 1045 | 0.010 |
Why?
|
| Binding Sites | 1 | 1993 | 1256 | 0.010 |
Why?
|
| Neoplasms | 1 | 1984 | 2952 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1994 | 907 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1992 | 1554 | 0.000 |
Why?
|
| RNA | 1 | 1992 | 552 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 2669 | 0.000 |
Why?
|
| Base Sequence | 1 | 1992 | 2900 | 0.000 |
Why?
|
| Gene Expression | 1 | 1992 | 1560 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1992 | 3771 | 0.000 |
Why?
|
| Cell Line | 1 | 1992 | 2725 | 0.000 |
Why?
|
| DNA | 1 | 1992 | 1478 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1984 | 99 | 0.000 |
Why?
|
| Mediastinal Neoplasms | 1 | 1984 | 42 | 0.000 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1984 | 79 | 0.000 |
Why?
|
| Syndrome | 1 | 1984 | 1174 | 0.000 |
Why?
|
| Pancreatic Neoplasms | 1 | 1984 | 728 | 0.000 |
Why?
|